| P50 | author | Bala Gur Dedeoglu | Q57095689 |
| | Emine Ezel Cilek | Q57095671 |
| P2093 | author name string | Hakime Ozturk | |
| P2860 | cites work | Predicting effective microRNA target sites in mammalian mRNAs | Q21128766 |
| | The ubiquitin-conjugating enzyme (E2) Ube2w ubiquitinates the N terminus of substrates | Q24605908 |
| | Comprehensive molecular portraits of human breast tumours | Q24630844 |
| | WebGestalt: an integrated system for exploring gene sets in various biological contexts | Q24813284 |
| | Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs | Q37564492 |
| | Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response | Q37722926 |
| | ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective | Q37970020 |
| | MiRNA‑542‑3p downregulation promotes trastuzumab resistance in breast cancer cells via AKT activation | Q38920320 |
| | A network-biology perspective of microRNA function and dysfunction in cancer | Q38994476 |
| | A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis | Q39099485 |
| | Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines | Q39820639 |
| | Detecting key genes regulated by miRNAs in dysfunctional crosstalk pathway of myasthenia gravis | Q43150803 |
| | Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment tools | Q44958136 |
| | FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma. | Q50850830 |
| | Using MCL to extract clusters from networks. | Q51481316 |
| | Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial. | Q54196115 |
| | Methods for biological data integration: perspectives and challenges | Q26778582 |
| | MicroRNA gene expression deregulation in human breast cancer | Q27860690 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | MicroRNA expression profiles classify human cancers | Q28032481 |
| | Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 |
| | Posttranscriptional regulation of microRNA biogenesis in animals | Q28282519 |
| | Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer | Q28729012 |
| | Got target? Computational methods for microRNA target prediction and their extension | Q28752466 |
| | Pathway and network analysis of cancer genomes | Q28914768 |
| | Identifying miRNA synergistic regulatory networks in heterogeneous human data via network motifs. | Q31031810 |
| | Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery | Q33479152 |
| | The relationship between the evolution of microRNA targets and the length of their UTRs | Q33502897 |
| | A genome-wide association study reveals variants in ARL15 that influence adiponectin levels | Q33518461 |
| | Processing of Agilent microRNA array data | Q33537410 |
| | Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients. | Q33747550 |
| | clusterMaker: a multi-algorithm clustering plugin for Cytoscape | Q34070756 |
| | MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN. | Q34179919 |
| | Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells | Q34181700 |
| | The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy. | Q34373936 |
| | Gene expression profiling of breast cell lines identifies potential new basal markers. | Q34467687 |
| | MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features | Q34559623 |
| | Practical Aspects of microRNA Target Prediction | Q35237559 |
| | Classification of Beta-lactamases and penicillin binding proteins using ligand-centric network models | Q35562890 |
| | MicroRNA function: multiple mechanisms for a tiny RNA? | Q36325449 |
| | Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast Cancer | Q36440214 |
| | MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients | Q36545717 |
| | MicroRNAs in disease and potential therapeutic applications | Q36945531 |
| | DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows | Q36953893 |
| | WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 | Q36954017 |
| | Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis | Q37368106 |
| | ErbB receptors and signaling pathways in cancer | Q37390082 |
| | Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients | Q37394399 |
| | Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. | Q37523202 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | trastuzumab | Q412616 |
| P304 | page(s) | e0185558 | |
| P577 | publication date | 2017-10-05 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines | |
| P478 | volume | 12 | |